| An opioid agonist that does not induce μ-opioid receptor—arrestin interactions or receptor internalization CE Groer, K Tidgewell, RA Moyer, WW Harding, RB Rothman, ... Molecular pharmacology 71 (2), 549-557, 2007 | 280 | 2007 |
| Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil D Zolkowska, R Jain, RB Rothman, JS Partilla, BL Roth, V Setola, ... Journal of Pharmacology and Experimental Therapeutics 329 (2), 738-746, 2009 | 210 | 2009 |
| Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to … LK Brents, A Gallus-Zawada, A Radominska-Pandya, T Vasiljevik, ... Biochemical pharmacology 83 (7), 952-961, 2012 | 197 | 2012 |
| Neoclerodane diterpenes as a novel scaffold for μ opioid receptor ligands WW Harding, K Tidgewell, N Byrd, H Cobb, CM Dersch, ER Butelman, ... Journal of medicinal chemistry 48 (15), 4765-4771, 2005 | 195 | 2005 |
| Gedunin, a novel Hsp90 inhibitor: semisynthesis of derivatives and preliminary structure− activity relationships GEL Brandt, MD Schmidt, TE Prisinzano, BSJ Blagg Journal of medicinal chemistry 51 (20), 6495-6502, 2008 | 190 | 2008 |
| Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum MW Johnson, KA MacLean, CJ Reissig, TE Prisinzano, RR Griffiths Drug and alcohol dependence 115 (1-2), 150-155, 2011 | 175 | 2011 |
| Psychopharmacology of the hallucinogenic sage Salvia divinorum TE Prisinzano Life sciences 78 (5), 527-531, 2005 | 161 | 2005 |
| Development of functionally selective, small molecule agonists at kappa opioid receptors L Zhou, KM Lovell, KJ Frankowski, SR Slauson, AM Phillips, JM Streicher, ... Journal of Biological Chemistry 288 (51), 36703-36716, 2013 | 154 | 2013 |
| R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse CJ Loland, M Mereu, OM Okunola, J Cao, TE Prisinzano, S Mazier, ... Biological psychiatry 72 (5), 405-413, 2012 | 147 | 2012 |
| Neuropharmacology of the naturally occurring κ-opioid hallucinogen salvinorin A CW Cunningham, RB Rothman, TE Prisinzano Pharmacological reviews 63 (2), 316-347, 2011 | 144 | 2011 |
| Kappa opioids and the modulation of pain B Kivell, TE Prisinzano Psychopharmacology 210, 109-119, 2010 | 144 | 2010 |
| Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria Y O'Malley, BD Fink, NC Ross, TE Prisinzano, WI Sivitz Journal of biological chemistry 281 (52), 39766-39775, 2006 | 142 | 2006 |
| Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects KA MacLean, MW Johnson, CJ Reissig, TE Prisinzano, RR Griffiths Psychopharmacology 226, 381-392, 2013 | 141 | 2013 |
| Salvinorin A analogs as probes in opioid pharmacology TE Prisinzano, RB Rothman Chemical reviews 108 (5), 1732-1743, 2008 | 122 | 2008 |
| Role of ventral subiculum in context-induced relapse to alcohol seeking after punishment-imposed abstinence NJ Marchant, EJ Campbell, LR Whitaker, BK Harvey, K Kaganovsky, ... Journal of Neuroscience 36 (11), 3281-3294, 2016 | 118 | 2016 |
| Pharmacokinetics of the plant‐derived κ‐opioid hallucinogen salvinorin A in nonhuman primates MD Schmidt, MS Schmidt, ER Butelman, WW Harding, K Tidgewell, ... Synapse 58 (3), 208-210, 2005 | 112 | 2005 |
| Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues AP Riley, CE Groer, D Young, AW Ewald, BM Kivell, TE Prisinzano Journal of medicinal chemistry 57 (24), 10464-10475, 2014 | 104 | 2014 |
| Flavonoids as opioid receptor ligands: identification and preliminary structure− Activity relationships PL Katavic, K Lamb, H Navarro, TE Prisinzano Journal of natural products 70 (8), 1278-1282, 2007 | 102 | 2007 |
| Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism B Kivell, Z Uzelac, S Sundaramurthy, J Rajamanickam, A Ewald, V Chefer, ... Neuropharmacology 86, 228-240, 2014 | 101 | 2014 |
| Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction RB Rothman, MH Baumann, TE Prisinzano, AH Newman Biochemical pharmacology 75 (1), 2-16, 2008 | 99 | 2008 |
